GE HEALTHCARE TECHNOLOGIES INC. vs KONINKLIJKE PHILIPS NV, two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where GEHC and PHG diverge most: on debt / equity, GEHC reads 0.95 and PHG reads 0.00; on revenue growth, GEHC reads +5.9% and PHG reads +1.0%. The rest of the comparable metrics sit closer together. On valuation, today's GEHC price has a different growth bar priced in than PHG (+8.4% implied for GEHC vs +8.9% for PHG); the higher figure is the steeper assumption to clear, not a better or worse stock. What GEHC's price implies is a bet that sits within the historical range (whole-company basis). What PHG's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | GEHC | PHG |
|---|---|---|
| Price | $68.03 | $26.30 |
| Market cap | $31.1B | $24.9B |
| Sector | Medical Devices | Medical Devices |
| Stage | Mature | Mature |
| Implied growth (priced in) | +8.4% | +8.9% |
| P/E | 16.3 | 25.7 |
| P/B | 2.91 | 2.09 |
| P/S | 1.48 | 1.29 |
| EV/EBITDA | 14.3 | 7.9 |
| Revenue growth | +5.9% | +1.0% |
| Gross margin | 38.5% | 45.2% |
| Operating margin | 10.0% | 8.0% |
| Net margin | 9.1% | 5.0% |
| Return on equity | 17.9% | 8.2% |
| Return on assets | 5.1% | 3.3% |
| Return on invested capital | 10.4% | 9.9% |
| FCF yield | -0.4% | -1.2% |
| Dividend yield | 0.2% | — |
| Debt / equity | 0.95 | 0.00 |
| Current ratio | 1.22 | 1.32 |
| Altman Z (solvency) | 1.60 | 1.81 |
| Piotroski F (quality) | 4 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.